Patients with chronic kidney disease and type 2 diabetes who took the experimental drug finerenone developed about a 30% less chance of developing atrial...
MINNEAPOLIS, February 17, 2021 / PRNewswire / - Metavention, Inc. announces the initiation of an FDA-cleared clinical investigation, DeLIVER (NCT04285554), for the company's iRF...